http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008137968-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate | 2007-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008137968-A |
| titleOfInvention | IMMUNOMODULATING AND ANTITUMOR PEPTIDES |
| abstract | 1. Peptides with antitumor and immunomodulating properties, originating from region 32-51 of the LALF protein, lacking the ability to bind LPS and heparin, including amino acid sequences: SEQ. ID NO: 1-4 and 8-12, and homologous variants of these peptides. ! 2. Chemical compounds mimicking peptides according to claim 1, wherein said chemical compounds have an antitumor effect and lack the ability to bind LPS and heparin. ! 3. A pharmaceutical composition comprising one or more peptides and chemical compounds according to claims 1 and 2 and also containing auxiliary agents or pharmaceutically acceptable carriers. ! 4. The pharmaceutical composition according to claim 3, where the specified composition further comprises an immunogen. ! 5. The pharmaceutical composition according to claim 4, where the specified immunogen is selected from the group consisting of immunogens of peptide, ganglioside or protein nature, being virus-like particles or protein vesicles of bacterial origin. ! 6. The use of peptides and chemical compounds, according to claims 1 and 2, in the manufacture of pharmaceutical compositions for the treatment and / or prevention of immunological diseases and cancer. ! 7. The use according to claim 6, where the application also includes an effective amount to stimulate the immune response in humans. ! 8. The use according to claim 6, where the use is characterized by using to inhibit metastases. |
| priorityDate | 2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756 |
Total number of triples: 18.